2.25
price down icon1.53%   -0.04
 
loading
전일 마감가:
$2.29
열려 있는:
$2.22
하루 거래량:
222.24K
Relative Volume:
0.90
시가총액:
$117.55M
수익:
$81.06M
순이익/손실:
$-55.55M
주가수익비율:
-1.9737
EPS:
-1.14
순현금흐름:
$-47.98M
1주 성능:
-15.70%
1개월 성능:
-14.91%
6개월 성능:
-63.51%
1년 성능:
-58.55%
1일 변동 폭
Value
$2.19
$2.54
1주일 범위
Value
$2.19
$2.785
52주 변동 폭
Value
$2.17
$8.45

Sight Sciences Inc Stock (SGHT) Company Profile

Name
명칭
Sight Sciences Inc
Name
전화
(415) 889-0550
Name
주소
4040 CAMPBELL AVE,, MENLO PARK
Name
직원
216
Name
트위터
Name
다음 수익 날짜
2025-03-05
Name
최신 SEC 제출 서류
Name
SGHT's Discussions on Twitter

SGHT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
SGHT
Sight Sciences Inc
2.25 117.55M 81.06M -55.55M -47.98M -1.14
Medical Devices icon
ABT
Abbott Laboratories
131.54 225.32B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
99.99 149.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
376.10 142.48B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
88.56 113.49B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
71.75 42.10B 5.72B 4.17B 259.90M 6.97

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-06 개시 UBS Buy
2024-11-04 다운그레이드 Lake Street Buy → Hold
2024-08-21 개시 Lake Street Buy
2023-09-12 다운그레이드 BofA Securities Neutral → Underperform
2023-09-12 다운그레이드 Piper Sandler Overweight → Neutral
2023-09-12 다운그레이드 William Blair Outperform → Mkt Perform
2023-08-24 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2023-07-10 다운그레이드 Citigroup Buy → Neutral
2023-01-06 업그레이드 Stifel Hold → Buy
2022-10-04 개시 Needham Hold
2022-07-26 개시 Stifel Hold
2022-02-03 개시 William Blair Outperform
2022-01-07 업그레이드 Morgan Stanley Equal-Weight → Overweight
모두보기

Sight Sciences Inc 주식(SGHT)의 최신 뉴스

pulisher
Mar 31, 2025

Charles Schwab Investment Management Inc. Raises Stock Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Looks Inexpensive But Perhaps Not Attractive Enough - simplywall.st

Mar 30, 2025
pulisher
Mar 29, 2025

Sight sciences chief legal officer sells shares worth $19,250 - MSN

Mar 29, 2025
pulisher
Mar 26, 2025

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th - GlobeNewswire

Mar 26, 2025
pulisher
Mar 25, 2025

Key Investor Updates Coming: Sight Sciences Takes Center Stage at Major Healthcare Conference - Stock Titan

Mar 25, 2025
pulisher
Mar 25, 2025

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Mar 25, 2025
pulisher
Mar 16, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of “Hold” from Analysts - Defense World

Mar 16, 2025
pulisher
Mar 15, 2025

Sight sciences EVP Manohar Raheja buys $53,250 in stock By Investing.com - Investing.com Australia

Mar 15, 2025
pulisher
Mar 13, 2025

Sight sciences EVP Manohar Raheja buys $53,250 in stock - Investing.com India

Mar 13, 2025
pulisher
Mar 09, 2025

Lake Street Capital Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $2.50 - The AM Reporter

Mar 09, 2025
pulisher
Mar 09, 2025

Sight Sciences’ (SGHT) Hold Rating Reiterated at Needham & Company LLC - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Piper Sandler Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $3.50 - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics - MSN

Mar 08, 2025
pulisher
Mar 08, 2025

Lake Street Capital Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Stifel Nicolaus Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Earnings call transcript: Sight Sciences Q4 2024 results miss forecasts By Investing.com - Investing.com Australia

Mar 08, 2025
pulisher
Mar 07, 2025

Actinic Keratosis Market Forecast 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Treatment, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail

Mar 07, 2025
pulisher
Mar 07, 2025

Sight Sciences Inc. (SGHT) reports earnings - Quartz

Mar 07, 2025
pulisher
Mar 07, 2025

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results, Initiates Full Year 2025 Financial Guidance - Vision Monday

Mar 07, 2025
pulisher
Mar 06, 2025

Sight Sciences Faces Headwinds in Glaucoma and Dry Eye Markets, Hold Rating Maintained - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Sight Sciences’ Earnings Call: Cautious Optimism Amid Challenges - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Sight Sciences price target lowered to $3.50 from $5.50 at Piper Sandler - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Stifel cuts Sight Sciences price target to $4, maintains Buy rating By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Stifel cuts Sight Sciences price target to $4, maintains Buy rating - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Sight Sciences Stock Hits 52-Week Low at $2.27 Amid Market Challenges - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Sight Sciences Stock Hits 52-Week Low at $2.27 Amid Market Challenges By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 06, 2025
pulisher
Mar 06, 2025

Citigroup Lowers Sight Sciences (NASDAQ:SGHT) Price Target to $3.00 - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Sight Sciences Reports 2024 Results and 2025 Outlook - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Earnings call transcript: Sight Sciences Q4 2024 results miss forecasts - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Sight Sciences Expects 2025 Revenue To Decline By 6% To 12% - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

Sight Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 05, 2025
pulisher
Mar 05, 2025

Sight Sciences Reports 2024 Financial Results and 2025 Outlook - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance - The Manila Times

Mar 05, 2025
pulisher
Mar 05, 2025

Sight Sciences earnings missed by $0.01, revenue fell short of estimates - Investing.com UK

Mar 05, 2025
pulisher
Mar 05, 2025

Sight Sciences Reports Fourth Quarter and Full Year 2024 - GlobeNewswire

Mar 05, 2025
pulisher
Mar 04, 2025

Breaking Down Sight Sciences: 6 Analysts Share Their Views - Benzinga

Mar 04, 2025
pulisher
Mar 04, 2025

908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 04, 2025
pulisher
Mar 03, 2025

Sight Sciences Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

March 2025 Penny Stocks To Consider For Growth - Simply Wall St

Mar 03, 2025
pulisher
Mar 03, 2025

Sight Sciences (SGHT) Projected to Post Earnings on Wednesday - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Sight Sciences (SGHT) to Release Quarterly Earnings on Wednesday - MarketBeat

Mar 01, 2025
pulisher
Feb 26, 2025

Will Sight Sciences, Inc. (SGHT) Report Negative Earnings Next Week? What You Should Know - MSN

Feb 26, 2025
pulisher
Feb 25, 2025

Institutional owners may consider drastic measures as Sight Sciences, Inc.'s (NASDAQ:SGHT) recent US$14m drop adds to long-term losses - Simply Wall St

Feb 25, 2025
pulisher
Feb 25, 2025

Sight Sciences To Present Clinical Data On OMNI Surgical System At AGS Annual Meeting 2025 - Nasdaq

Feb 25, 2025
pulisher
Feb 24, 2025

Sight Sciences stock hits 52-week low at $2.47 amid market challenges - Investing.com Nigeria

Feb 24, 2025
pulisher
Feb 24, 2025

Sight Sciences to Present Comprehensive Clinical Data on - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Can This Groundbreaking Glaucoma Treatment Transform Patient Care? New Data Reveals 3-Year Outcomes - StockTitan

Feb 24, 2025
pulisher
Feb 24, 2025

Sight Sciences stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa

Feb 24, 2025

Sight Sciences Inc (SGHT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
medical_devices STE
$227.12
price up icon 0.69%
medical_devices ZBH
$112.20
price down icon 0.15%
medical_devices PHG
$24.82
price down icon 1.68%
$67.68
price up icon 0.74%
$79.18
price down icon 0.49%
medical_devices EW
$71.74
price down icon 0.19%
자본화:     |  볼륨(24시간):